<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01701908</url>
  </required_header>
  <id_info>
    <org_study_id>PPC2012</org_study_id>
    <nct_id>NCT01701908</nct_id>
    <nct_alias>NCT01914328</nct_alias>
  </id_info>
  <brief_title>Postoperative Pulmonary Complications in Abdominal Surgery</brief_title>
  <official_title>Postoperative Pulmonary Complications in Major (Abdominal) Surgery: a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Udine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Udine</source>
  <brief_summary>
    <textblock>
      Incidence of Postoperative Pulmonary Complications (PPCs) varies from 2% to 19%, according to&#xD;
      the population under examination and the criteria used to define pulmonary complications.&#xD;
      There is no univocal definition of PPCs. Usually physicians associate atelectasis,&#xD;
      respiratory insufficiency, pneumonia, bronchospasm, necessity to reintubate. Moreover the&#xD;
      evaluation of risk factors has become difficult.&#xD;
&#xD;
      The endpoint of this study is to determine the actual incidence of respiratory postoperative&#xD;
      complications in patients undergoing general anesthesia for major abdominal surgery (general&#xD;
      surgery, gynecology, urology).&#xD;
&#xD;
      This is an observational, descriptive, prospective, multicentric study. Investigators are&#xD;
      going to enroll all the patients matching the inclusion criteria and follow them until&#xD;
      discharge (clinical phase). Then they will be followed up until one year later.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTRODUCTION Pulmonary Postoperative Complications (PPCs) are among the most common causes of&#xD;
      adverse events in the perioperative period and can determine a significant increase of&#xD;
      mortality risk in hospitalization time.&#xD;
&#xD;
      Incidence of PPCs varies from 2% to 19%, according to the population under examination and&#xD;
      the criteria used to define pulmonary complications. There is no univocal definition of PPCs.&#xD;
      Usually physicians associate atelectasis, respiratory insufficiency, pneumonia, bronchospasm,&#xD;
      necessity of tracheal reintubation. Moreover, the evaluation of risk factors is becoming&#xD;
      increasingly difficult. Many aspects linked to the patient's conditions and postoperative&#xD;
      anesthesiologic management have been demonstrated to influence the risk of developing PPCs.&#xD;
      (with the endorsement of European Society of Anesthesiology) proposed a risk index based on&#xD;
      seven perioperative parameters to predict PPCs probability.&#xD;
&#xD;
      Furthermore, patients who survive after pulmonary complications will still suffer from&#xD;
      functional reductions and are at risk of having a decrease in medium and long-term survival.&#xD;
&#xD;
      PRIMARY END POINT To determine the actual incidence of respiratory postoperative&#xD;
      complications in patients undergoing general anesthesia for major abdominal surgery (general&#xD;
      surgery, urology, gynecology).&#xD;
&#xD;
      Respiratory complications are: pneumonia, respiratory insufficiency 8,9, pleural effusion,&#xD;
      pneumothorax, atelectasia, ab ingestis pneumonia, necessity of oxygen supply, non invasive&#xD;
      mechanical ventilation (NIMV) or tracheal reintubation.&#xD;
&#xD;
      SECONDARY END POINTS&#xD;
&#xD;
      To determine:&#xD;
&#xD;
        -  postoperative incidence of necessity of tracheal reintubation&#xD;
&#xD;
        -  duration of mechanical ventilatory support&#xD;
&#xD;
        -  postoperative incidence of infections&#xD;
&#xD;
        -  postoperative incidence of PostOperative Residual Curarization (PORC)&#xD;
&#xD;
        -  postoperative incidence of cardiovascular complications&#xD;
&#xD;
        -  postoperative outcome (30, 60 days and one year later)&#xD;
&#xD;
        -  time of hospital stay, hospital mortality&#xD;
&#xD;
        -  necessity of admission to ICU and ICU length of stay&#xD;
&#xD;
      Duration of the clinical phase: hospitalization (data collection: two hours after discharge&#xD;
      from the operating room, then from the first, up to the fifth postoperative day) Duration of&#xD;
      follow-up after hospitalization (follow up period): 30 days - 60 days - 1 year.&#xD;
&#xD;
      RECRUITMENT AND MONITORING PROCEDURES All patients scheduled for elective major abdominal&#xD;
      surgery, urologic surgery or major gynecological surgery under general anaesthesia will be&#xD;
      enrolled in this study.&#xD;
&#xD;
      Patients will be enrolled over a 15 days period, after that, if the sample would be too&#xD;
      small, another 15 days enrollment period will be repeated.&#xD;
&#xD;
      During the preoperative evaluation, the anesthesiologist will expose the study protocol to&#xD;
      all patients who will match the inclusion criteria. The informed consent will be obtained.&#xD;
&#xD;
      Patients will be monitored in the postoperative period and will receive, standard&#xD;
      postoperative care, as directed by the clinical teams and if indicated, antibiotics,&#xD;
      diuretics, oxygen therapy and every therapy according to the underlying disease. Medical and&#xD;
      nursing staff will monitor peripheral oxygen saturation in the origin ward.&#xD;
&#xD;
      In every center a researcher will evaluate the enrolled patients daily, checking for&#xD;
      peripheral oxygen saturation, arterial pressure, heart rate, respiratory rate, body&#xD;
      temperature and pain assessment (NRS scale).&#xD;
&#xD;
      Patient's clinical status until the hospital discharge will be reported on case report forms&#xD;
      (CRFs). Every intraoperative parameter (like drugs used, the need of blood transfusion, fluid&#xD;
      management and fluid balance at the end of surgery) will be recorded.&#xD;
&#xD;
      Treatments and therapy will be continued according to clinicians decision and will be&#xD;
      recorded in the CRF.&#xD;
&#xD;
      The decision to start an oxygen therapy or a ventilatory support (invasive or non-invasive)&#xD;
      or to admit the patient to the ICU will be taken by clinicians of every single participating&#xD;
      center according to their guidelines.&#xD;
&#xD;
      Every device used, with oxygen flow values, FiO2, PEEP and ventilation mode&#xD;
      (assisted/mechanical) will be noted in the CRF.&#xD;
&#xD;
      Antibiotic therapy and any pathogen responsible for pneumonia will be noted on the CRF.&#xD;
&#xD;
      Anesthesiologist will evaluate all the patients two hours after their return in the ward, and&#xD;
      from the first to the fifth postoperative day. Anesthesiologists will be also on-call by the&#xD;
      attending physician or the nursing staff every time patient's clinical conditions will need&#xD;
      it.&#xD;
&#xD;
      Every patient will be followed (and will be enrolled in the study) until hospital discharge.&#xD;
      Date of discharge will be noted in the CRF.&#xD;
&#xD;
      Moreover every enrolled patient will be followed-up at 30, 60 days and a year after hospital&#xD;
      discharge, to verify the patients health status and to evaluate the incidence of&#xD;
      re-hospitalization and mortality.&#xD;
&#xD;
      DATA COLLECTION:&#xD;
&#xD;
      A form divided in three sections (pre/intra/postoperative period) will be used for data&#xD;
      collection. Data will be collected on paper support and then entered in an electronic CRF.&#xD;
&#xD;
      Data will be anonymous. Every patient will be identified by a six number code: first three&#xD;
      (from left to right) identify the participating center, the others identify the sequential&#xD;
      number of enrollment.&#xD;
&#xD;
      The data insertion will be done by the investigators of every participating center, using&#xD;
      personal username and password.&#xD;
&#xD;
      Data will be sent to the coordinator center where the data cleaning will be completed and&#xD;
      statistical analysis will be performed with this timing:&#xD;
&#xD;
      after the 15 days enrolment period; after 4 months from the beginning of the study (30 days&#xD;
      postoperative follow up); after 6 months from the beginning of the study (60 days&#xD;
      postoperative follow up); after 16 months from the beginning of the study (1 year&#xD;
      postoperative follow up) Every center will store its own paper CRF.&#xD;
&#xD;
      In the preoperative section will be recorded the patient's data about:&#xD;
&#xD;
      age, weight, height, sex; comorbidities (neurological, cardiovascular, metabolic, renal,&#xD;
      muscular-skeletal) respiratory history positive for: previous pleuro-parenchymal diseases in&#xD;
      the 30 days before surgery, previous chest, pleural or lung surgery, presence of pleural&#xD;
      effusion; history of cigarettes smoking: active smoker (number of cigarettes), ex-smoker or&#xD;
      not smoker; history of alcohol abuse (active potus, previous or abstinent); active cancer&#xD;
      (excluding the diagnosis for surgery); SpO2, PaO2, PaO2/FiO2, PaCO2 when available; white&#xD;
      cell number, hemoglobin and preoperative creatinine; ASA class; presence of nasogastric tube&#xD;
      before surgery; presence of urinary catheter before surgery; blood products transfusion&#xD;
      before surgery.&#xD;
&#xD;
      In the intraoperative section will be recorded the patient's data about:&#xD;
&#xD;
      type of surgery; type of anaesthesia (TIVA, balanced); type of analgesia (intravenous,&#xD;
      epidural, perineural block); preoperative antibiotic prophylaxis; blood products transfusion;&#xD;
      intraoperative fluid management (crystalloids Vs colloids, mL/Kg/h); type of ventilation&#xD;
      (PCV/VCV); ventilation parameters (TV, Pins, PEEP, RR, FiO2); recruitment maneuvers (yes/no)&#xD;
      (manuals, pressure controlled); intraoperative ventilatory problems ( (SpO2 &lt; 90%, PaO2/FiO2&#xD;
      &lt; 300, PaCO2 &gt; 45 mmHg, increase of airways pressure over than 30 cmH2O, bronchospasm, needs&#xD;
      of TV&gt; 10 mL/Kg); hemorrhage or need of blood products transfusion; cardiovascular problems&#xD;
      (hypotension, tachycardia, bradycardia, arrhythmia) and use of cardio/vasoactive drugs;&#xD;
&#xD;
        -  length of surgery;&#xD;
&#xD;
        -  use of qualitative or quantitative (TOF Watch) neuromuscular transmission monitoring&#xD;
           systems use of neostigmine or sugammadex&#xD;
&#xD;
        -  Final TOF ratio&#xD;
&#xD;
      In the postoperative section will be recorded the following data:&#xD;
&#xD;
      pain score at discharge from the operating room and up to the fifth postoperative day; needs&#xD;
      of blood products transfusion in the postoperative period; stay of nasogastric tube;&#xD;
&#xD;
        -  stay of urinary catheter;&#xD;
&#xD;
        -  postoperative respiratory complications;&#xD;
&#xD;
        -  postoperative non-respiratory complications (cardiovascular, renal, surgical,&#xD;
           infections)&#xD;
&#xD;
        -  needs of re-intubation in the postoperative period;&#xD;
&#xD;
        -  needs of ventilatory support (non invasive ventilation, invasive ventilation) in the&#xD;
           postoperative period; needs of ICU admission (planned, unplanned, cause, length of ICU&#xD;
           stay); length of hospital stay; 30, 60 days and 1 year mortality (specify the cause).&#xD;
&#xD;
      STATISTICAL PLANS&#xD;
&#xD;
      Investigators are going to enroll 1500 patients undergoing elective major abdominal surgery,&#xD;
      in a period of 15 days. Investigator decided to enroll all the patients in a limited period&#xD;
      of time (as in LAS VEGAS [for more information...see www.euroanaesthesia.org., European&#xD;
      Society of Anesthesiology (ESA) Clinical Trial Network]) and, if the sample size will not be&#xD;
      sufficient, it will be possible to add 15 extra days. On the basis of works published by&#xD;
      Squadrone et. al.[11] (16%), Lawrence et.al. [17] (4,5%), Hall et. al. [18] (15%), Mitchell&#xD;
      et.al. [19] (11%) and Canet et. al. (7,2%) [10], the hypothesis was that the incidence of&#xD;
      primary outcome (PaO2 /FiO2≤ 300) will be 7%.&#xD;
&#xD;
      The sample size has been calculated using alpha = 0,05 (2-tailed test) and CI of 95%.&#xD;
&#xD;
      The result of this calculation is a sample size of 1422. Investigators decided to enroll 1500&#xD;
      patients because this way our population will be heterogeneous and because of possible&#xD;
      deviations from the protocol.&#xD;
&#xD;
      The statistic analysis will include:&#xD;
&#xD;
        -  descriptive statistics of all the collected data (average, median, standard deviation,&#xD;
           interquartile range, minimum and maximum for the continuous variables; relative and&#xD;
           absolute frequency for the qualitative variables&#xD;
&#xD;
        -  interdependence between two or more variables (if present)&#xD;
&#xD;
        -  Statistic comparison between continuous variables, using t-Student test (if the variable&#xD;
           has a normal distribution) or non-parametric tests.&#xD;
&#xD;
        -  Comparison between qualitative variables, using Chi-square test&#xD;
&#xD;
        -  Odds ratio&#xD;
&#xD;
        -  Logistic regression&#xD;
&#xD;
        -  The study will include the possibility to perform non-planned analyses, if useful.&#xD;
&#xD;
      The data will be saved on an electronic support, using the Softwares Epi info 2002 (CDC),&#xD;
      SPSS11.0 (SPSS) and STATA 9.0 (STATA), when appropriate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Postoperative Pulmonary Complications</condition>
  <eligibility>
    <study_pop>
      <textblock>
        1500 patients undergoing elective major abdominal surgery, urologic surgery or major&#xD;
        gynecological surgery under general anaesthesia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients ≥ 18 years&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Elective surgery&#xD;
&#xD;
          -  Laparotomic or laparoscopic major abdominal surgery&#xD;
&#xD;
          -  Major urological surgery (performed under general anesthesia)&#xD;
&#xD;
          -  Major gynecological surgery (performed under general anesthesia)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing urgent or emergent surgery&#xD;
&#xD;
          -  Patients undergoing: vascular, thoracic ,cardiac surgery, neurosurgery, obstetrics&#xD;
             procedures and transplantation surgery&#xD;
&#xD;
          -  Patients with chronic neuro-muscular junction disorders&#xD;
&#xD;
          -  Immunocompromised or immunodepressed patients&#xD;
&#xD;
          -  Patients with chronic or acute respiratory disease (acute respiratory infection,&#xD;
             bronchial asthma, chronic obstructive pulmonary disease, sleep apnea syndrome)&#xD;
&#xD;
          -  Patients with preoperative mechanical ventilation&#xD;
&#xD;
          -  Patients with preoperative SpO2 &lt;90%, PaO2 &lt;60 mmHg (FiO2 0.21), or a PaO2/FiO2 ratio&#xD;
             &lt;300, or PaCO2 &gt;45 mmHg.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giorgio Della Rocca, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Udine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giorgio Della Rocca, Professor</last_name>
    <phone>+39 0432 559501</phone>
    <email>giorgio.dellarocca@uniud.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Desenzano Hospital</name>
      <address>
        <city>Desenzano del Garda</city>
        <state>Brescia</state>
        <zip>25015</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicola Petrucci</last_name>
      <email>ni.petrucci@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Nicola Petrucci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>C.E.S.A.T. S. Pietro Igneo Hospital</name>
      <address>
        <city>Fucecchio</city>
        <state>Firenze</state>
        <zip>50054</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Emanuele Mori</last_name>
      <email>emanuele.mori@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Emanuele Mori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <state>Monza e Brianza</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Roberto Fumagalli</last_name>
      <email>r.fumagalli@hsgerardo.org</email>
    </contact>
    <investigator>
      <last_name>Roberto Fumagalli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ceccarini Hospital</name>
      <address>
        <city>Riccione</city>
        <state>Rimini</state>
        <zip>47838</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Alessandro Gatta</last_name>
      <email>alessandrogatta@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Alessandro Gatta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute For Cancer Research And Treatment</name>
      <address>
        <city>Candiolo</city>
        <state>Torino</state>
        <zip>10060</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Bona</last_name>
      <email>mantis96@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Francesco Bona, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.Luigi Gonzaga Hospital</name>
      <address>
        <city>Orbassano</city>
        <state>Torino</state>
        <zip>10043</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Augusto Tempia</last_name>
      <email>augusto.tempia@unito.it</email>
    </contact>
    <investigator>
      <last_name>Augusto Tempia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Valentino Hospital</name>
      <address>
        <city>Montebelluna</city>
        <state>Treviso</state>
        <zip>31044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care Medicine of the Medical School of the University of Udine (Coordinating center)</name>
      <address>
        <city>Udine</city>
        <state>UD</state>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giorgio Della Rocca, Professor</last_name>
      <phone>+39 0432 559501</phone>
      <email>giorgio.dellarocca@uniud.it</email>
    </contact>
    <investigator>
      <last_name>Giorgio Della Rocca, MD, Professor, PI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlandi Hospital</name>
      <address>
        <city>Bussolengo</city>
        <state>Verona</state>
        <zip>37012</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Plinio Calligaro</last_name>
      <email>pcalligaro@ulss22.ven.it</email>
    </contact>
    <investigator>
      <last_name>Plinio Calligaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Italian National Research Centres On Aging</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Gabriella Bettelli</last_name>
      <email>g.bettelli@inrca.it</email>
    </contact>
    <investigator>
      <last_name>Gabriella Bettelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardinal Massaia Hospital</name>
      <address>
        <city>Asti</city>
        <zip>14100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Agostino Roasio</last_name>
      <email>aroasio@asl.at.it</email>
    </contact>
    <investigator>
      <last_name>Agostino Roasio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bari Hospital</name>
      <address>
        <city>Bari</city>
        <zip>70131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Salvatore Grasso</last_name>
      <email>sgrasso@rianima.uniba.it</email>
    </contact>
    <investigator>
      <last_name>Salvatore Grasso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.Orsola-Malpighi Hospital</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Maurizio Fusari</last_name>
      <email>maurizio.fusari@fastwebnet.it</email>
    </contact>
    <investigator>
      <last_name>Maurizio Fusari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catania Hospital (Policlinico)</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Antonino Gullo</last_name>
      <email>a.gullo@policlinico.unict.it</email>
    </contact>
    <investigator>
      <last_name>Antonino Gullo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cannizzaro Emergency Hospital</name>
      <address>
        <city>Catania</city>
        <zip>95126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Luigi Vicari</last_name>
      <email>mednemo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luigi Vicari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Anna Hospital</name>
      <address>
        <city>Ferrara</city>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Teresa Matarazzo</last_name>
      <email>t.matarazzo@ospfe.it</email>
    </contact>
    <investigator>
      <last_name>Teresa Matarazzo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mugello Hospital</name>
      <address>
        <city>Firenze</city>
        <zip>50122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Vieri Parrini</last_name>
      <email>vieri.parrini@asf.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Vieri Parrini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S. Maria Nuova Hospital</name>
      <address>
        <city>Firenze</city>
        <zip>50123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Antonio Franco</last_name>
      <email>antonio.franco@asf.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Franco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Careggi Hospital</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Raffaele De Gaudio</last_name>
      <email>rdegaudio@tin.it</email>
    </contact>
    <investigator>
      <last_name>Raffaele De Gaudio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Martino</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Luigi Spagnolo</last_name>
      <email>luigispagnolo1@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Luigi Spagnolo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fazzi Hospital</name>
      <address>
        <city>Lecce</city>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Luigi Fuggiano</last_name>
      <email>luigifuggiano@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luigi Fuggiano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Macerata Hospital</name>
      <address>
        <city>Macerata</city>
        <zip>62100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giuseppe Tappata</last_name>
      <email>giuseppe.tappatà@sanita.marche.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Tappata, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mantova Hospital</name>
      <address>
        <city>Mantova</city>
        <zip>46100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Vincenzo Sgarioto</last_name>
      <email>vincenzo.sgarioto@aopoma.it</email>
    </contact>
    <investigator>
      <last_name>Vincenzo Sgarioto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS S. Raffaele, Milano</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Elena Bignami, MD</last_name>
      <email>bignami.elena@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Elena Bignami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giacomo Moniti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>European Institute Of Oncology</name>
      <address>
        <city>Milano</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniele Sances</last_name>
      <email>daniele.sances@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Daniele Sances, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Paolo Hospital, University Of Milano</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Concezione Tommasino</last_name>
      <email>concezione.tommasino@unimi.it</email>
    </contact>
    <investigator>
      <last_name>Tommasino Concezione, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Niguarda Ca' Granda, Milano</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Ines Arpino</last_name>
      <email>inesarpino@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ines Arpino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federico II Hospital</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Rosalba Tufano</last_name>
      <email>rtufano@unina.it</email>
    </contact>
    <investigator>
      <last_name>Rosalba Tufano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Major Charity Hospital</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Valeria Viarengo</last_name>
      <email>valeria.viarengo@maggioreosp.novara.it</email>
    </contact>
    <investigator>
      <last_name>Valeria Viarengo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Matteo Hospital</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Antonio Braschi</last_name>
      <email>antonio.braschi@unipv.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Braschi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.Maria of Mercy Hospital</name>
      <address>
        <city>Perugia</city>
        <zip>06156</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Paola Fabbricini</last_name>
      <email>paola.fabbriccini@unipg.it</email>
    </contact>
    <investigator>
      <last_name>Paola Fabbricini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nuovo Santa Chiara Hospital</name>
      <address>
        <city>Pisa</city>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Francesco Forfori</last_name>
      <email>forforiden@libero.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Forfori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prato Hospital</name>
      <address>
        <city>Prato</city>
        <zip>59100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Guglielmo Consales</last_name>
      <email>gconsales@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Guglielmo Consales, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Umberto I, &quot;Sapienza&quot;, University of Rome</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Franco Ruberto</last_name>
      <email>rube2005@libero.it</email>
    </contact>
    <investigator>
      <last_name>Franco Ruberto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maurizio Marandola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Gazzanelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Di Marco Pierangelo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic University Hospital A. Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Paolo Primieri</last_name>
      <email>p.primieri@libero.it</email>
    </contact>
    <investigator>
      <last_name>Paolo Primieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Giovanni Battista Hospital</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Elisabetta Cerutti</last_name>
      <email>ecerutti@molinette.piemonte.it</email>
    </contact>
    <investigator>
      <last_name>Elisabetta Cerutti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.Maria di Ca' Foncello</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Roberto Nani</last_name>
      <email>rnani@ulss.tv.it</email>
    </contact>
    <investigator>
      <last_name>Roberto Nani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Smetana GW. Preoperative pulmonary evaluation. N Engl J Med. 1999 Mar 25;340(12):937-44. Review.</citation>
    <PMID>10089188</PMID>
  </reference>
  <reference>
    <citation>Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006 Apr 18;144(8):581-95. Review.</citation>
    <PMID>16618956</PMID>
  </reference>
  <reference>
    <citation>Fleischmann KE, Goldman L, Young B, Lee TH. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med. 2003 Nov;115(7):515-20.</citation>
    <PMID>14599629</PMID>
  </reference>
  <reference>
    <citation>Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ; Participants in the VA National Surgical Quality Improvement Program. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005 Sep;242(3):326-41; discussion 341-3.</citation>
    <PMID>16135919</PMID>
  </reference>
  <reference>
    <citation>Fisher BW, Majumdar SR, McAlister FA. Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies. Am J Med. 2002 Feb 15;112(3):219-25. Review.</citation>
    <PMID>11893349</PMID>
  </reference>
  <reference>
    <citation>Antonelli M, Conti G, Bufi M, Costa MG, Lappa A, Rocco M, Gasparetto A, Meduri GU. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000 Jan 12;283(2):235-41.</citation>
    <PMID>10634340</PMID>
  </reference>
  <reference>
    <citation>Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care. 2005;9(6):R687-93. Epub 2005 Nov 8.</citation>
    <PMID>16356219</PMID>
  </reference>
  <reference>
    <citation>Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. 1997 Mar;111(3):564-71.</citation>
    <PMID>9118688</PMID>
  </reference>
  <reference>
    <citation>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003 Feb 20;348(8):683-93.</citation>
    <PMID>12594312</PMID>
  </reference>
  <reference>
    <citation>Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J, Sabaté S, Mazo V, Briones Z, Sanchis J; ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010 Dec;113(6):1338-50. doi: 10.1097/ALN.0b013e3181fc6e0a.</citation>
    <PMID>21045639</PMID>
  </reference>
  <reference>
    <citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012 Sep 22;380(9847):1059-65. doi: 10.1016/S0140-6736(12)61148-9.</citation>
    <PMID>22998715</PMID>
  </reference>
  <reference>
    <citation>Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA, Stanley JC, Upchurch GR Jr. Variation in postoperative complication rates after high-risk surgery in the United States. Surgery. 2003 Oct;134(4):534-40; discussion 540-1.</citation>
    <PMID>14605612</PMID>
  </reference>
  <reference>
    <citation>McAlister FA, Bertsch K, Man J, Bradley J, Jacka M. Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med. 2005 Mar 1;171(5):514-7. Epub 2004 Nov 24.</citation>
    <PMID>15563632</PMID>
  </reference>
  <reference>
    <citation>Gupta H, Gupta PK, Fang X, Miller WJ, Cemaj S, Forse RA, Morrow LE. Development and validation of a risk calculator predicting postoperative respiratory failure. Chest. 2011 Nov;140(5):1207-1215. doi: 10.1378/chest.11-0466. Epub 2011 Jul 14.</citation>
    <PMID>21757571</PMID>
  </reference>
  <reference>
    <citation>Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334-49. Review.</citation>
    <PMID>10793167</PMID>
  </reference>
  <reference>
    <citation>Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, Belloni G, Vilianis G, Fiore G, Cavallo F, Ranieri VM; Piedmont Intensive Care Units Network (PICUN). Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA. 2005 Feb 2;293(5):589-95.</citation>
    <PMID>15687314</PMID>
  </reference>
  <reference>
    <citation>Lawrence VA, Dhanda R, Hilsenbeck SG, Page CP. Risk of pulmonary complications after elective abdominal surgery. Chest. 1996 Sep;110(3):744-50.</citation>
    <PMID>8797421</PMID>
  </reference>
  <reference>
    <citation>Hall JC, Tarala RA, Hall JL. Respiratory insufficiency after abdominal surgery. Respirology. 1996 Jun;1(2):133-8.</citation>
    <PMID>9434329</PMID>
  </reference>
  <reference>
    <citation>Mitchell CK, Smoger SH, Pfeifer MP, Vogel RL, Pandit MK, Donnelly PJ, Garrison RN, Rothschild MA. Multivariate analysis of factors associated with postoperative pulmonary complications following general elective surgery. Arch Surg. 1998 Feb;133(2):194-8.</citation>
    <PMID>9484734</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <study_first_submitted>September 30, 2012</study_first_submitted>
  <study_first_submitted_qc>October 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2012</study_first_posted>
  <last_update_submitted>October 5, 2012</last_update_submitted>
  <last_update_submitted_qc>October 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Udine</investigator_affiliation>
    <investigator_full_name>Giorgio Della Rocca</investigator_full_name>
    <investigator_title>MD, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>PPCs</keyword>
  <keyword>abdominal surgery</keyword>
  <keyword>postoperative infections</keyword>
  <keyword>postoperative residual curarization</keyword>
  <keyword>tracheal re-intubation</keyword>
  <keyword>mortality</keyword>
  <keyword>ICU stay</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

